Lion Biotechnologies, Inc. — Form D

Lion Biotechnologies, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2011-01-21. The offering totals $640K, of which $640K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Mark J AhnDirectorPortland, OR
Robert T BrookeDirectorMANHATTAN BEACH, CA
Richard T McKilliganDirectorMANHATTAN BEACH, CA
Robert T BrookeExecutive OfficerMANHATTAN BEACH, CA
Richard T McKilliganExecutive OfficerMANHATTAN BEACH, CA
Ibrahim J AbotalebPromoterMANHATTAN BEACH, CA
Gerald J LewisPromoterMANHATTAN BEACH, CA
Jay VenkatesanDirectorBoston, MA
Maria FardisDirectorSan Francisco, CA
Maria FardisExecutive OfficerSan Francisco, CA
Anthony CataldoDirectorBeverly Hills, CA
Anthony CataldoExecutive OfficerBeverly Hills, CA
Paul KesslerDirectorLos Angeles, CA
Sanford J HillsbergDirectorLos Angeles, CA
Molly C HendersonExecutive OfficerNew York, NY
Michael T LotzeExecutive OfficerNew York, NY
Merrill McPeakDirectorNew York, NY
Merrill McPeakExecutive OfficerNew York, NY
Steven A FischkoffExecutive OfficerNew York, NY
Wayne J RothbaumDirectorNew York, NY
Ryan J MaynardDirectorNew York, NY
Michael HandelmanDirectorBeverly Hills, CA
Michael HandelmanExecutive OfficerBeverly Hills, CA
Manish SinghDirectorFremont, CA
Manish SinghExecutive OfficerFremont, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2016-06-15D$100.0M$100.0M
2013-11-15D$23.3M$23.3M
2013-06-06D$1.4M$1.4M
2011-08-09D$5.0M$5.0M
2011-05-03D$1.0M$500K
2010-11-08D$250K$250K
2010-10-01D$500K$500K

More